SCHEMBL1134032

SCHEMBL1134032

CCOC(=O)C(C)(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1278919 0.97 ALOX15 (0.46)
Hydrochloric Acid SCHEMBL4880200 0.95 MMP8 (0.44)
SCHEMBL4618149 0.93 GAA (0.42)
SCHEMBL4270735 0.87 ALOX15 (0.38)
SCHEMBL8632493 0.84
SCHEMBL22747722 0.84 ALOX15 (0.48)
Hydrochloric Acid SCHEMBL30098258 0.82 ALOX15 (0.46)
SCHEMBL28521932 0.82
Hydrochloric Acid SCHEMBL28694338 0.82 ALOX15 (0.46)
Hydrochloric Acid SCHEMBL10531755 0.82 ALOX15 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113620825-B Microchannel reactor and method for preparing ethyl dimethylaminoacetate by using microchannel reactor 浙江海昇药业股份有限公司 2023-10-13 CN claimed
CN-113620825-A Micro-channel reactor and method for preparing dimethylamino ethyl acetate by using same 浙江海昇药业股份有限公司 2021-11-09 CN claimed
CN-109336965-A A kind of synthetic method of carazolol artificial antigen 江南大学 2019-02-15 CN claimed
EP-1603549-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS Yu, Ruey J., Dr. (US) 2005-12-14 EP claimed
WO-2004082628-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS YU RUEY J (US) 2004-09-30 WO claimed
US-5696268-A REACTING N-ACYLAMINO ACID DERIVATIVE WITH OPTICALLY ACTIVE ENAMINE DERIVATIVE, REACTING PRODUCT WITH AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-12-09 US claimed
US-5644059-A REACTION OF KETONE WITH ACRYLAMIDE AND AMMONIA OR AMMONIUM SALT FUJIREBIO INC. (JP) 1997-07-01 US claimed
EP-0488345-A1 1,4-Dihydropyridine derivatives and methods of producing the same FUJIREBIO INC. (JP) 1992-06-03 EP claimed
US-12465049-B2 Pest control method, and pest control agent composition and pest control agent set NIPPON SODA CO., LTD. (JP) 2025-11-11 US disclosed
EP-4608810-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS Septerna, Inc. (US) 2025-09-03 EP disclosed
WO-2025073290-A1 VPS4 INHIBITORS AND METHODS OF USE THEREOF PARA THERAPEUTICS, INC. (US) 2025-04-10 WO disclosed
CN-119552087-A Synthesis method of dialkylamino alcohol 福建纯铭新材料科技有限公司 2025-03-04 CN disclosed
CN-119215800-A Microchannel reaction device and application thereof 中国石油化工股份有限公司 2024-12-31 CN disclosed
CN-114621222-B 6-6 Fused bicyclic heteroaryl compounds and their use as LATS inhibitors 诺华股份有限公司 2024-12-17 CN disclosed
US-4727060-A HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1988-02-23 US disclosed
US-4680392-A Substituted caprolactam derivatives as antihypertensives MERCK & CO., INC. (US) 1987-07-14 US disclosed
US-4629787-A ANGIOTENSIN CONVERTING ENZYME INHIBITORS MERCK & CO., INC. (US) 1986-12-16 US disclosed
US-4616002-A HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1986-10-07 US disclosed
EP-0046291-B1 SUBSTITUTED CAPROLACTAM DERIVATIVES AS ANTIHYPERTENSIVES, PROCESS FOR PREPARING THEM, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND INTERMEDIATES MERCK & CO. INC. (US) 1985-12-27 EP disclosed
EP-0046291-A2 Substituted caprolactam derivatives as antihypertensives, process for preparing them, pharmaceutical composition containing them, and intermediates MERCK & CO. INC. (US) 1982-02-24 EP disclosed